Covered recipient · General Payments record
RULA M SAEED
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$477.27
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.54 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $79.19 | 3 |
| LivaNova USA, Inc. | $68.43 | 2 |
| Neurelis, Inc. | $48.63 | 2 |
| Amneal Pharmaceuticals LLC | $43.03 | 1 |
| UCB, Inc. | $39.12 | 2 |
| ARGENX US, INC. | $25.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.08 | 1 |
| Biogen, Inc. | $19.54 | 1 |
| TG THERAPEUTICS, INC. | $19.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $21.08 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093914745 | CMS |
| Amneal Pharmaceuticals LLC | $43.03 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139200422 | CMS |
| ARGENX US, INC. | $25.45 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119857 | CMS |
| Biogen, Inc. | $19.54 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104842328 | CMS |
| Genentech USA, Inc. | $25.03 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133102738 | CMS |
| Genentech USA, Inc. | $29.04 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133102742 | CMS |
| Genentech USA, Inc. | $25.12 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133102747 | CMS |
| LivaNova USA, Inc. | $30.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790159 | CMS |
| LivaNova USA, Inc. | $38.43 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152790247 | CMS |
| Neurelis, Inc. | $19.76 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145652784 | CMS |
| Neurelis, Inc. | $28.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145652786 | CMS |
| TG Therapeutics, Inc. | $19.07 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136882698 | CMS |
| UCB, Inc. | $21.30 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143145416 | CMS |
| UCB, Inc. | $17.82 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143145425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.